Impaired neurogenesis is associated with elevated levels of glucocorticoids and decreased expression of brain derived neurotrophic factor (BDNF), both of have been observed in patients with T2D and AD (Marosi and Mattson, 2014; Dey et al., 2017). This evidence concerns the gene BDNF and Alzheimer disease.